Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis
Y Wang, Y Kong, Q Yang, C Zhong, D Zhou… - European Journal of …, 2024 - Elsevier
Background The rarity yet high malignancy of gallbladder adenocarcinoma (GBA) endows it
with a distinctive nature. Radical resection remains the foremost therapeutic approach for …
with a distinctive nature. Radical resection remains the foremost therapeutic approach for …
[HTML][HTML] Poor clinical outcomes and immunoevasive contexture in CD161+ CD8+ T cells barren human pancreatic cancer
Q Chen, H Yin, Z Jiang, T He, Y Xie… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Background The role of CD161 expression on CD8+ T cells in tumor immunology has been
explored in a few studies, and the clinical significance of CD161+ CD8+ T cells in pancreatic …
explored in a few studies, and the clinical significance of CD161+ CD8+ T cells in pancreatic …
A commentary on 'Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal …
F Zhong, C Xieb, X Peng, J Luo… - International Journal of …, 2024 - journals.lww.com
The combination of upfront pancreatectomy followed by adjuvant chemotherapy (AC)
remains the established treatment for resectable pancreatic ductal adenocarcinoma (PDAC) …
remains the established treatment for resectable pancreatic ductal adenocarcinoma (PDAC) …
Non-surgical pancreatic cancer: The role of radiotherapy in prolonging survival, A retrospective cohort study in the SEER database
D Yupeng, J Song, Z Sun, Y Wang, L Meng - International Journal of … - journals.lww.com
Background: Limited research has compared external beam radiotherapy (RT) to non-RT in
patients with non-surgical locally advanced pancreatic cancer (LAPC). Therefore, this study …
patients with non-surgical locally advanced pancreatic cancer (LAPC). Therefore, this study …
Evaluating the Benefits of Adjuvant Chemotherapy in Patients with Pancreatic Cancer Undergoing Radical Pancreatectomy after Neoadjuvant Therapy-A Systematic …
J Wu, Y Zhang, H Wang, W Guo, C Li, Y Yu… - Available at SSRN … - papers.ssrn.com
Background: More and more patients with pancreatic cancer (PC) received neoadjuvant
therapy (NAT) and then underwent radical pancreatectomy. However, the benefit of adjuvant …
therapy (NAT) and then underwent radical pancreatectomy. However, the benefit of adjuvant …